Definium Therapeutics DFTX
NASDAQ DFTX
$38.41 +2.24 (+6.19%)
At close: Sep 28, 2026 · 4:00 PM EDT

Definium Therapeutics (DFTX) Net Equity Issued and Repurchased (2021 - 2026)

Updated

Definium Therapeutics' Net Equity Issued and Repurchased was $801.17 million in Q2 2026.

Analysis

Definium Therapeutics (DFTX) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Definium Therapeutics' Net Equity Issued and Repurchased was $1.06 billion through Jun 30, 2026, up 332.0% year-over-year; for FY2025, it was $258.86 million, up 3.5% from FY2024.

  • Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 29.2% (FY2020 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $250 million in FY2024, $7.53 million in FY2023 (-82.2%), $42.3 million in FY2022 (-48.4%) and $81.92 million in FY2021 (+13.8%).
  • The Q2 2026 figure marks the highest quarterly Net Equity Issued and Repurchased in data going back to Q1 2021.
  • The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q4 2023 (growth of 915.8%); the worst was Q1 2022 (a decline of 99.9%).
  • Per Business Quant data, DFTX's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $3.83 million (Q1 2026), $257.85 million (Q4 2025) and $425,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 6.00 Mn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 9.00 Mn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 47.70 Mn
10 Definium Therapeutics 4.00 Bn 4.00 Bn - 801.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 801.17 Mn
Mar 31, 2026 3.83 Mn
Dec 31, 2025 257.85 Mn
Sep 30, 2025 425,000.00
Mar 31, 2025 579,000.00
Dec 31, 2024 245.57 Mn
Jun 30, 2024 2.73 Mn
Mar 31, 2024 1.70 Mn
Dec 31, 2023 7.42 Mn
Sep 30, 2023 -1.74 Mn
Jun 30, 2023 1.27 Mn
Mar 31, 2023 583,000.00
Dec 31, 2022 730,000.00
Sep 30, 2022 40.86 Mn
Jun 30, 2022 585,000.00
Mar 31, 2022 123,000.00
Sep 30, 2021 -4,000.00
Jun 30, 2021 -185,000.00
Mar 31, 2021 82.11 Mn
API Access

Definium Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=DFTX&period=max&api_key=YOUR_API_KEY